EClinicalMedicine
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Durvalumab and tremelimumab in patients with advanced rare cancer: a multi-centre, non-blinded, open-label phase II basket trial.
79:102991.
2025
-
Corrigendum to "Differential efficacy of medical therapies for ulcerative colitis according to disease extent: patient-level analysis from multiple randomized controlled trials" volume 72, 102621..
78:102980.
2024
-
Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials..
76:102835.
2024
-
Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery: a multicentre, randomised, double-blind, parallel group, phase 2a trial..
76:102830.
2024
-
The missing clinical guidance: a scoping review of care for autistic transgender and gender-diverse people..
76:102849.
2024
-
Cost effectiveness analysis of a fixed dose combination pill for primary prevention of cardiovascular disease from an individual participant data meta-analysis.
73:102651-102651.
2024
-
Differential efficacy of medical therapies for ulcerative colitis according to disease extent: patient-level analysis from multiple randomized controlled trials.
72:102621-102621.
2024
-
Tobacco use and risk of acute stroke in 32 countries in the INTERSTROKE study: a case–control study.
70:102515-102515.
2024
-
Effects of RBT-1 on preconditioning response biomarkers in patients undergoing coronary artery bypass graft or heart valve surgery: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial.
68:102364-102364.
2024
-
A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials.
65:102283-102283.
2023
-
Antibiotic prescribing guideline recommendations in COVID-19: a systematic survey.
65:102257-102257.
2023
-
Time to establish an international vaccine candidate pool for potential highly infectious respiratory disease: a community’s view.
64:102222-102222.
2023
-
Early Omicron infection is associated with increased reinfection risk in older adults in long-term care and retirement facilities.
63:102148-102148.
2023
-
Patterns of patient-reported symptoms and association with sociodemographic and systemic sclerosis disease characteristics: a scleroderma Patient-centered Intervention Network (SPIN) Cohort cross-sectional study.
62:102104-102104.
2023
-
Comparing SARS-CoV-2 testing positivity rates and COVID-19 impact among different isolation strategies: a rapid systematic review and a modelling study.
61:102058-102058.
2023
-
Response to letter by Campbell et al. regarding the results of the COSTICK trial.
61:102054-102054.
2023
-
Population attributable fraction of hypertension for dementia: global, regional, and national estimates for 186 countries.
60:102012-102012.
2023
-
Rivaroxaban to prevent major clinical outcomes in non-hospitalised patients with COVID-19: the CARE – COALITION VIII randomised clinical trial.
60:102004-102004.
2023
-
Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019.
59:101936-101936.
2023
-
Surgical outcomes of gallbladder cancer: the OMEGA retrospective, multicentre, international cohort study.
59:101951-101951.
2023
-
Labia minora elongation: a neglected form of genital mutilation with mental and sexual health concerns.
58:101879-101879.
2023
-
Dietary counselling to reduce moderate sodium intake: effects on cardiovascular and renal biomarkers: primary findings of the COSIP and STICK phase II feasibility randomised controlled trials.
57:101856-101856.
2023
-
Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis.
57:101860-101860.
2023
-
Validating fatty acid binding protein 3 as a diagnostic and prognostic biomarker for peripheral arterial disease: a three-year prospective follow-up study.
55:101766-101766.
2023
-
Living alone and all-cause mortality in community-dwelling adults: A systematic review and meta-analysis.
54:101677-101677.
2022
-
Health and social outcomes in the Housing First model: Testing the theory of change.
47:101387-101387.
2022
-
Inactivated SARS-CoV-2 vaccine for people with HIV.
45:101327-101327.
2022
-
Biofire FilmArray Meningitis/Encephalitis panel for the aetiological diagnosis of central nervous system infections: A systematic review and diagnostic test accuracy meta-analysis.
44:101275-101275.
2022
-
Variations in the financial impact of the COVID-19 pandemic across 5 continents: A cross-sectional, individual level analysis.
44:101284-101284.
2022
-
Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized Trial.
42:101188-101188.
2021
-
Psychiatric disorders in individuals born very preterm / very low-birth weight: An individual participant data (IPD) meta-analysis.
42:101216-101216.
2021
-
Adolescent cognitive function and incident early-onset type 2 diabetes.
41:101138-101138.
2021
-
Corrigendum to ‘A comparison of electronically-delivered and face to face cognitive behavioural therapies in depressive disorders: A systematic review and meta-analysis’ [EClinicalMedicine 24 (2020) 100442].
41:101182-101182.
2021
-
Effect of co-infection with intestinal parasites on COVID-19 severity: A prospective observational cohort study.
39:101054-101054.
2021
-
Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses.
36:100884-100884.
2021
-
Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial.
36:100926-100926.
2021
-
Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine.
36:100928-100928.
2021
-
A systematic review and meta-analysis of discharged COVID-19 patients retesting positive for RT-PCR.
34:100839-100839.
2021
-
Adjuvant melatonin for the prevention of recurrence and mortality following lung cancer resection (AMPLCaRe): A randomized placebo controlled clinical trial.
33:100763-100763.
2021
-
Low sodium intake increases plasma renin activity.
33:100803-100803.
2021
-
Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: A systematic literature review and network meta-analysis.
28:100573-100573.
2020
-
Addendum to ‘A comparison of electronically-delivered and face to face cognitive behavioural therapies in depressive disorders: A systematic review and meta-analysis’ [EClinicalMedicine 24 (2020) 100442].
27:100580-100580.
2020
-
A comparison of electronically-delivered and face to face cognitive behavioural therapies in depressive disorders: A systematic review and meta-analysis.
24:100442-100442.
2020
-
Maternal outcomes and birth interventions among women who begin labour intending to give birth at home compared to women of low obstetrical risk who intend to give birth in hospital: A systematic review and meta-analyses.
21:100319-100319.
2020
-
Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: A systematic literature review and meta-analysis.
18:100237-100237.
2020
-
Caution is needed when assessing results of home birth–Authors’ reply.
16:17-17.
2019
-
Perinatal or neonatal mortality among women who intend at the onset of labour to give birth at home compared to women of low obstetrical risk who intend to give birth in hospital: A systematic review and meta-analyses.
14:59-70.
2019
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)